Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Conroy

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|April 1, 1980
Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in miceP J Conroy, R Von Burg, D P Penney, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1979
Misonidazole neurotoxicity in the mouse: evaluation of functional, pharmacokinetic, electrophysiologic and morphologic parametersP J Conroy, R Von Burg, W Passalacqua, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificityR M Sutherland, P Keng, P J Conroy, et al.
Biochemical Pharmacology|May 15, 1976
Metronidazole (Flagyl), a radiosensitiser of possible clinical use in cancer chemotherapy: some biochemical and pharmacological considerationsM N Eakins, P J Conroy, A J Searle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Nitroimidazole neurotoxicity: are mouse studies predictive?P J Conroy, T H McNeill, W Passalacqua, et al.
Radiation Research|April 1, 1985
Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cellsJ S Rasey, K A Krohn, Z Grunbaum, et al.
Toxicology and Applied Pharmacology|January 1, 1981
Somatosensory deficits in monkeys treated with misonidazoleJ P Maurissen, P J Conroy, W Passalacqua, et al.
Nature Communications|May 20, 2021
FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophyA J Wood, C H Lin, M Li, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|April 1, 1980
Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in miceP J Conroy, R Von Burg, D P Penney, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1979
Misonidazole neurotoxicity in the mouse: evaluation of functional, pharmacokinetic, electrophysiologic and morphologic parametersP J Conroy, R Von Burg, W Passalacqua, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificityR M Sutherland, P Keng, P J Conroy, et al.
Biochemical Pharmacology|May 15, 1976
Metronidazole (Flagyl), a radiosensitiser of possible clinical use in cancer chemotherapy: some biochemical and pharmacological considerationsM N Eakins, P J Conroy, A J Searle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Nitroimidazole neurotoxicity: are mouse studies predictive?P J Conroy, T H McNeill, W Passalacqua, et al.
Radiation Research|April 1, 1985
Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cellsJ S Rasey, K A Krohn, Z Grunbaum, et al.
Toxicology and Applied Pharmacology|January 1, 1981
Somatosensory deficits in monkeys treated with misonidazoleJ P Maurissen, P J Conroy, W Passalacqua, et al.
Nature Communications|May 20, 2021
FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophyA J Wood, C H Lin, M Li, et al.
Pageof 2